KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 85 filers reported holding KALA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 7.30 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $53,000 | -44.2% | 20,240 | +12.9% | 0.01% | -40.0% |
Q2 2021 | $95,000 | -22.8% | 17,929 | -1.7% | 0.01% | -28.6% |
Q1 2021 | $123,000 | -57.4% | 18,240 | -57.2% | 0.01% | -70.2% |
Q4 2020 | $289,000 | +16.5% | 42,665 | +29.1% | 0.05% | +17.5% |
Q3 2020 | $248,000 | -28.7% | 33,041 | -0.2% | 0.04% | -23.1% |
Q2 2020 | $348,000 | – | 33,102 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Athyrium Capital Management, LP | 1,333,333 | $5,073,000 | 100.00% |
CAXTON CORP | 1,483,343 | $5,644,000 | 6.36% |
Polaris Venture Management Co. V, L.L.C. | 1,197,032 | $4,555,000 | 2.59% |
RA Capital Management | 4,537,478 | $17,265,000 | 1.03% |
Orbimed Advisors | 3,447,840 | $13,119,000 | 0.25% |
Matisse Capital | 46,500 | $177,000 | 0.22% |
PURA VIDA INVESTMENTS, LLC | 332,831 | $1,266,000 | 0.22% |
Sofinnova Investments, Inc. | 478,206 | $1,819,000 | 0.16% |
HARBOURVEST PARTNERS LLC | 99,186 | $377,000 | 0.16% |
ALGERT GLOBAL LLC | 47,195 | $180,000 | 0.07% |